方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABIO 方舟生物医药

盘前交易 07-26 07:22:20 EDT

3.07

-0.03

-0.97%

最高3.15	最低2.95	成交量12.28万
今开3.10	昨收3.10	日振幅6.29%
总市值4,454万	流通市值1,501万	总股本1,451万
成交额37.09万	换手率2.51%	流通股本488.97万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABIO","market":"US","secType":"STK","nameCN":"方舟生物医药","latestPrice":3.07,"timestamp":1721937600000,"preClose":3.1,"halted":0,"volume":122822,"delay":0,"floatShares":4889744,"shares":14507143,"eps":-0.41569,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.03,"latestTime":"07-26 07:22:20 EDT","open":3.1,"high":3.145,"low":2.95,"amount":370944.4619846,"amplitude":0.062903,"askPrice":3.33,"askSize":100,"bidPrice":2.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.41569,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722000600000},"adr":0,"listingDate":871012800000,"adjPreClose":3.07,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.07,"latestTime":"17:39 EDT","volume":180,"amount":564.66,"timestamp":1721943579368},"volumeRatio":1.1287002403740765,"impliedVol":0.9948,"impliedVolPercentile":0.1594},"requestUrl":"/m/hq/s/ABIO","defaultTab":"news","newsList":[{"id":"2452433799","title":"方舟生物医药盘中异动 早盘急速下挫5.16%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452433799","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452433799?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:09","pubTimestamp":1721315357,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时09分，方舟生物医药股票出现异动，股价大幅下挫5.16%。截至发稿，该股报3.31美元/股，成交量7.3608万股，换手率0.51%，振幅8.60%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.08%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230917aefa59af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718230917aefa59af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2451623038","title":"方舟生物医药盘中异动 股价大涨6.57%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623038","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451623038?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:57","pubTimestamp":1721051848,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时57分，方舟生物医药股票出现波动，股价急速拉升6.57%。截至发稿，该股报3.57美元/股，成交量2.2164万股，换手率0.15%，振幅1.23%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.42%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715215729941f70f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715215729941f70f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2449998298","title":"方舟生物医药盘中异动 大幅下跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449998298","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449998298?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:35","pubTimestamp":1720186510,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时35分，方舟生物医药股票出现波动，股价快速跳水6.34%。截至发稿，该股报3.25美元/股，成交量2870股，换手率0.02%，振幅2.59%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.65%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213510aef82cfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213510aef82cfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2448633433","title":"方舟生物医药盘中异动 股价大跌5.82%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448633433","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448633433?lang=zh_cn&edition=full","pubTime":"2024-07-04 00:46","pubTimestamp":1720025178,"startTime":"0","endTime":"0","summary":"北京时间2024年07月04日00时46分，方舟生物医药股票出现波动，股价急速下挫5.82%。截至发稿，该股报3.40美元/股，成交量10.4919万股，换手率0.72%，振幅9.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.01百万美元，每股收益-0.14美元，毛利-19000.00美元，市盈率-8.20倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为1.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004619aef7cdb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704004619aef7cdb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2448619975","title":"方舟生物医药盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448619975","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448619975?lang=zh_cn&edition=full","pubTime":"2024-07-03 04:01","pubTimestamp":1719950499,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日04时01分，方舟生物医药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报3.61美元/股，成交量13.251万股，换手率0.91%，振幅8.95%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.75%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703040139941f32f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703040139941f32f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2446685525","title":"方舟生物医药盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446685525","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446685525?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:47","pubTimestamp":1719582438,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时47分，方舟生物医药股票出现异动，股价快速拉升5.38%。截至发稿，该股报3.79美元/股，成交量6901股，换手率0.05%，振幅0.07%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.03%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214719aef729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214719aef729a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2443675524","title":"方舟生物医药盘中异动 早盘急速跳水5.07%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675524","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443675524?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:54","pubTimestamp":1718373283,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时54分，方舟生物医药股票出现异动，股价急速跳水5.07%。截至发稿，该股报3.15美元/股，成交量6565股，换手率0.05%，振幅4.16%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.01%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215444aef50953&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614215444aef50953&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2442842667","title":"方舟生物医药盘中异动 早盘急速跳水8.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442842667","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442842667?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:32","pubTimestamp":1718026333,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时32分，方舟生物医药股票出现异动，股价大幅跳水8.54%。截至发稿，该股报3.00美元/股，成交量4.3777万股，换手率0.30%，振幅3.05%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.49%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061021321395a0bd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061021321395a0bd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2440796235","title":"方舟生物医药盘中异动 股价大涨5.09%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440796235","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440796235?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:31","pubTimestamp":1717507882,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时31分，方舟生物医药股票出现波动，股价快速上涨5.09%。截至发稿，该股报3.92美元/股，成交量2.615万股，换手率0.18%，振幅4.92%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.16%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131229f19160f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406042131229f19160f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2440349345","title":"方舟生物医药盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440349345","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440349345?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:31","pubTimestamp":1717421506,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时31分，方舟生物医药股票出现异动，股价大幅拉升6.08%。截至发稿，该股报3.93美元/股，成交量6.2683万股，换手率0.43%，振幅2.70%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.35%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131479f156b7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032131479f156b7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2440944772","title":"方舟生物医药盘中异动 大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440944772","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440944772?lang=zh_cn&edition=full","pubTime":"2024-06-01 03:15","pubTimestamp":1717182930,"startTime":"0","endTime":"0","summary":"北京时间2024年06月01日03时15分，方舟生物医药股票出现波动，股价大幅拉升5.19%。截至发稿，该股报3.65美元/股，成交量4.3095万股，换手率0.30%，振幅4.61%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.62%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601031531aef2d25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240601031531aef2d25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2438590372","title":"方舟生物医药盘中异动 早盘股价大涨6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438590372","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438590372?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:33","pubTimestamp":1716903224,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时33分，方舟生物医药股票出现异动，股价大幅拉升6.78%。截至发稿，该股报3.62美元/股，成交量9479股，换手率0.07%，振幅0.29%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.86%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213344941ea9cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213344941ea9cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2437051762","title":"方舟生物医药盘中异动 早盘股价大涨5.83%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437051762","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437051762?lang=zh_cn&edition=full","pubTime":"2024-05-24 23:22","pubTimestamp":1716564126,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日23时22分，方舟生物医药股票出现异动，股价快速拉升5.83%。截至发稿，该股报3.45美元/股，成交量2.5851万股，换手率0.18%，振幅5.52%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.56%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524232206aef19870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524232206aef19870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2435541092","title":"方舟生物医药盘中异动 股价大跌5.00%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435541092","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435541092?lang=zh_cn&edition=full","pubTime":"2024-05-15 01:50","pubTimestamp":1715709004,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日01时50分，方舟生物医药股票出现异动，股价大幅下跌5.00%。截至发稿，该股报3.23美元/股，成交量4.4649万股，换手率0.31%，振幅7.48%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.09%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515015005861ed24b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515015005861ed24b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2435378229","title":"方舟生物医药盘中异动 股价大跌9.57%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378229","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435378229?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:30","pubTimestamp":1715607044,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时30分，方舟生物医药股票出现波动，股价急速下跌9.57%。截至发稿，该股报3.14美元/股，成交量1.5071万股，换手率0.10%，振幅9.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.00%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213044861eccb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213044861eccb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2434852835","title":"方舟生物医药盘中异动 早盘急速拉升5.28%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852835","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434852835?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:00","pubTimestamp":1715349620,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时00分，方舟生物医药股票出现异动，股价快速上涨5.28%。截至发稿，该股报3.55美元/股，成交量1.572万股，换手率0.11%，振幅4.74%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为0.40%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102200217a5941bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102200217a5941bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2432797086","title":"方舟生物医药盘中异动 早盘股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432797086","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432797086?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:33","pubTimestamp":1714743206,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时33分，方舟生物医药股票出现波动，股价快速上涨6.13%。截至发稿，该股报3.46美元/股，成交量1376股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.15%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133267925c0c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032133267925c0c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2432687208","title":"方舟生物医药盘中异动 下午盘快速跳水5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432687208","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432687208?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:17","pubTimestamp":1714587463,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时17分，方舟生物医药股票出现异动，股价大幅跳水5.73%。截至发稿，该股报3.29美元/股，成交量4.2484万股，换手率0.29%，振幅6.02%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体涨幅为1.31%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020217447a57df05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020217447a57df05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO","BK4139"],"gpt_icon":0},{"id":"2430027065","title":"方舟生物医药盘中异动 快速拉升5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430027065","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430027065?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:31","pubTimestamp":1714138292,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时31分，方舟生物医药股票出现异动，股价快速拉升5.75%。截至发稿，该股报3.68美元/股，成交量1.0512万股，换手率0.07%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。方舟生物医药股票所在的生物技术行业中，整体跌幅为0.50%。rNAPc2针对有凝血功能障碍生物标志物证据的COVID-19患者，而Gencaro正在开发用于具有识别与提高疗效相关的药物靶标，用于治疗基因型的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621313387b3f094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042621313387b3f094&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABIO"],"gpt_icon":0},{"id":"2430268389","title":"ARCA biopharma(ABIO.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.14美元，前值为-0.09美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430268389","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430268389?lang=zh_cn&edition=full","pubTime":"2024-04-26 05:55","pubTimestamp":1714082125,"startTime":"0","endTime":"0","summary":"ARCA biopharma(ABIO.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.14美元，前值为-0.09美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260555418b5468ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260555418b5468ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcabiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0725},{"period":"1month","weight":-0.1401},{"period":"3month","weight":-0.1425},{"period":"6month","weight":0.822},{"period":"1year","weight":0.5049},{"period":"ytd","weight":0.8059}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"方舟生物医药公司是一家生物制药公司,该公司主要致力于心血管疾病的基因疗法。公司的领先候选产品是Gencaro TM，一种有效的β受体阻滞剂同时还是温和的血管舒张药，正被开发用于治疗心房纤维颤动患者的心脏衰竭。公司已经识别出在心血管系统中常见的基因变异，并认为这与Gencaro的药理有关，并能预测病人对药物的反应。2009年1月27日，公司根据并购重组条款与ARCA科罗拉多完成业务合并，Nuvelo公司的全资子公司并入ARCA科罗拉多，ARCA科罗拉多州继续作为合并存续公司并成为Nuvelo公司的子公司，合并后，公司从Nuvelo更名为ARCA生物制药公司。Nuvelo最初注册名为Hyseq公司，于1992年在伊利诺伊州注册，并于1993年在内华达州重新注册。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.061348},{"month":2,"riseRate":0.375,"avgChangeRate":-0.063833},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.030249},{"month":4,"riseRate":0.5625,"avgChangeRate":0.101192},{"month":5,"riseRate":0.5,"avgChangeRate":0.09678},{"month":6,"riseRate":0.25,"avgChangeRate":0.477078},{"month":7,"riseRate":0.5,"avgChangeRate":0.015167},{"month":8,"riseRate":0.066667,"avgChangeRate":-0.142547},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.075747},{"month":10,"riseRate":0.4,"avgChangeRate":-0.066754},{"month":11,"riseRate":0.666667,"avgChangeRate":0.018484},{"month":12,"riseRate":0.533333,"avgChangeRate":0.003511}],"exchange":"NASDAQ","name":"方舟生物医药","nameEN":"ARCA biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方舟生物医药,ABIO,方舟生物医药股票,方舟生物医药股票老虎,方舟生物医药股票老虎国际,方舟生物医药行情,方舟生物医药股票行情,方舟生物医药股价,方舟生物医药股市,方舟生物医药股票价格,方舟生物医药股票交易,方舟生物医药股票购买,方舟生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方舟生物医药(ABIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方舟生物医药(ABIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}